← Back to Search

Medication take back education intervention for Opioid Use Disorder

N/A
Waitlist Available
Led By Michele A Hendrickson, MD,MS
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-discharge days 8-10
Awards & highlights

Study Summary

This trial is testing different strategies to reduce the number of opioids left over after surgery for kids.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-discharge days 8-10
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-discharge days 8-10 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assess participation in medication home disposal through follow up phone interview questionnaire.
Assess participation in medication take back through follow up phone interview questionnaire.
Quantification of residual opioids.
Secondary outcome measures
Average daily pain scores reported as values on Numerical Rating Scale.
Frequency of opioid consumption through follow up phone interview questionnaire.
Identify noncompliance/unsafe behaviors that contribute to retention of residual opioids through follow up phone interview questionnaire.
Other outcome measures
Actions related to residual opioids
Barriers to disposal of residual opioids through study specific follow up phone interview questionnaire.
Demographic data
+5 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Medication take back education interventionExperimental Treatment1 Intervention
Patients in this group will receive usual care from the acute pain medicine service, and will go home with standardized multimodal analgesic protocol as described in the control group. They will receive a standardized education intervention. This intervention will educate patients and their families about medication take back programs, and will provide tailored directions to the closest medication take back center from their home, and also an option for medication take back that is located in close proximity to Riley Hospital clinics.
Group II: Home disposal kit interventionExperimental Treatment1 Intervention
Patients in this group will receive usual care from the acute pain medicine service, and will go home with standardized multimodal analgesic protocol as described in the control group. They will receive standardized education about how to use the medication home disposal kit : Dispose Rx(r), and they will be instructed to use this kit to dispose of any left over opioid medications that they may have after they have competed therapy for pain management at home.
Group III: ControlActive Control1 Intervention
Patients in this group will receive usual care from the acute pain medicine service, and will go home with standardized multimodal analgesic protocol. There will be no interventions provided. They will receive a follow up phone call survey and be asked to return a completed medication education calendar that is provided as a part of usual APS care.

Find a Location

Who is running the clinical trial?

The Society for Pediatric AnesthesiaOTHER
3 Previous Clinical Trials
5,000,250 Total Patients Enrolled
Indiana UniversityLead Sponsor
980 Previous Clinical Trials
982,899 Total Patients Enrolled
LCMC HealthOTHER
3 Previous Clinical Trials
147 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~16 spots leftby Apr 2025